Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: More parallels than distinctions?

Trends in Parasitology

Volumn 29, Issue 12, 2013, Pages 593-602

  Butler, Noah S ^a   Harris, Tajie H ^b   Blader, Ira J ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

IL 10; IL 27; Immunopathology; Plasmodium; TGF ; Toxoplasma

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APICOMPLEXAN INFECTION; BONE MARROW CELL; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; ENDOTHELIUM CELL; ERYTHROCYTE; HELPER CELL; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MICROENVIRONMENT; NATURAL KILLER CELL; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PIROPLASMOSIS; PLASMODIUM; PLASMODIUM CHABAUDI; REVIEW; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TACHYZOITE; TH2 CELL; TOXOPLASMA; TOXOPLASMOSIS;

APICOMPLEXA; PLASMODIUM (APICOMPLEXA); PLASMODIUM PARASITES; TOXOPLASMA;

IL-10; IL-27; IMMUNOPATHOLOGY; PLASMODIUM; TGF-Β; TOXOPLASMA;

ANIMALS; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MALARIA; PLASMODIUM; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84888133819     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.10.002     Document Type: Review

References (110)

1. Stumhofer J.S., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
2. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 1996, 157:798-805.
3. Wilson E.H., et al. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J. Neuroimmunol. 2005, 165:63-74.
4. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
5. Butler N.S., et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 2012, 13:188-195.
6. + T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9196-9201.
7. Gigley J.P., et al. T cell exhaustion in protozoan disease. Trends Parasitol. 2012, 28:377-384.
8. Jacobs T., et al. Murine malaria is exacerbated by CTLA-4 blockade. J. Immunol. 2002, 169:2323-2329.
9. Jacobs T., et al. CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria. Eur. J. Immunol. 2004, 34:972-980.
10. Lepenies B., et al. CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections. Microbes Infect. 2007, 9:687-694.
11. Hafalla J.C., et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog. 2012, 8:e1002504.
12. + natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 2010, 6:e1001221.
13. Charles E., et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect. Immun. 2010, 78:3484-3492.
14. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
15. Kuhn R., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
16. Suzuki Y., et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 2000, 164:5375-5382.
17. Couper K.N., et al. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 2008, 4:e1000004.
18. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007, 204:273-283.
19. Roers A., et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 2004, 200:1289-1297.
20. Li C., et al. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor α and exacerbated by anti-transforming growth factor β antibodies. Infect. Immun. 2003, 71:4850-4856.
21. Linke A., et al. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 1996, 84:253-263.
22. Mun H.S., et al. Pathogenicity of Toxoplasma gondii through B-2 cell-mediated downregulation of host defense responses. Microbiol. Immunol. 2003, 47:533-542.
23. + T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 2012, 188:1178-1190.
24. Ouma C., et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum. Genet. 2008, 124:515-524.
25. Wilson J.N., et al. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun. 2005, 6:462-466.
26. Prakash D., et al. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J. Infect. Dis. 2006, 194:198-207.
27. Thuma P.E., et al. Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J. Infect. Dis. 2011, 203:211-219.
28. Ong'echa J.M., et al. Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect. Immun. 2011, 79:4674-4680.
29. Pinzon-Charry A., et al. Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J. Exp. Med. 2013, 210:1635.
30. Lundie R.J., et al. Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells. Eur. J. Immunol. 2010, 40:1674-1681.
31. Gorelik L., et al. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 2002, 195:1499-1505.
32. Li M.O., Flavell R.A. TGF-β: a master of all T cell trades. Cell 2008, 134:392-404.
33. de Kossodo S., Grau G.E. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 1993, 151:4811-4820.
34. Shikani H.J., et al. Cerebral malaria: we have come a long way. Am. J. Pathol. 2012, 181:1484-1492.
35. Perkins D.J., et al. Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. J. Infect. Dis. 2001, 183:113-118.
36. de Souza J.B., et al. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 2010, 137:755-772.
37. + T cell accumulation within the brain. J. Immunol. 2012, 189:968-979.
38. Howland S.W., et al. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol. Med. 2013, 5:984-999.
39. + T cells. Immunity 2009, 31:131-144.
40. Handel U., et al. Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis. Am. J. Pathol. 2012, 181:163-173.
41. Buzoni-Gatel D., et al. Murine ileitis after intracellular parasite infection is controlled by TGF-β-producing intraepithelial lymphocytes. Gastroenterology 2001, 120:914-924.
42. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
43. Takeda A., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003, 170:4886-4890.
44. Hall A.O., et al. The immunobiology of IL-27. Adv. Immunol. 2012, 115:1-44.
45. Villarino A.V., et al. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 2006, 176:237-247.
46. Hall A.O., et al. The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012, 37:511-523.
47. Findlay E.G., et al. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 2010, 185:2482-2492.
48. Villegas-Mendez A., et al. IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals. PLoS Pathog. 2013, 9:e1003293.
49. + T cell chemotactic responses during infection. J. Immunol. 2013, 190:4553-4561.
50. Stumhofer J.S., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
51. Awasthi A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
52. + inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008, 29:306-317.
53. + monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 2005, 201:1761-1769.
54. Sponaas A.M., et al. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 2009, 114:5522-5531.
55. Grainger J.R., et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat. Med. 2013, 19:713-721.
56. Chua C.L., et al. Monocytes and macrophages in malaria: protection or pathology?. Trends Parasitol. 2013, 29:26-34.
57. Wong K.A., Rodriguez A. Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. J. Immunol. 2008, 180:716-726.
58. Svensson M., et al. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 2004, 21:805-816.
59. Scholzen A., et al. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFβ. PLoS Pathog. 2009, 5:e1000543.
60. Ohkura N., et al. Development and maintenance of regulatory T cells. Immunity 2013, 38:414-423.
61. Josefowicz S.Z., et al. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30:531-564.
62. + regulatory T cells, immune stimulation and host defence against infection. Immunology 2012, 136:1-10.
63. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005, 23:287-296.
64. Walther M., et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009, 5:e1000364.
65. Minigo G., et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 2009, 5:e1000402.
66. Scholzen A., et al. Heroes or villains? T regulatory cells in malaria infection. Trends Parasitol. 2010, 26:16-25.
67. Freitas do Rosario A.P., Langhorne J. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int. J. Parasitol. 2012, 42:549-555.
68. Couper K.N., et al. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J. Immunol. 2009, 182:3985-3994.
69. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
70. Benson A., et al. Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J. Immunol. 2012, 188:800-810.
71. Perez-Villar J.J., et al. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 1999, 19:2903-2912.
72. Gary-Gouy H., et al. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 2002, 168:232-239.
73. Kalampokis I., et al. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 2013, 15(Suppl. 1):S1.
74. + regulatory B cells following Babesia microti-infection. PLoS ONE 2012, 7:e46553.
75. Tang H., et al. Development of adult worms and granulomatous pathology are collectively regulated by T- and B-cells in mice infected with Schistosoma japonicum. PLoS ONE 2013, 8:e54432.
76. Riley E.M., et al. Regulating immunity to malaria. Parasite Immunol. 2006, 28:35-49.
77. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
78. + T cells in the protective immune response to Plasmodium chabaudi in vivo. Immunol. Lett. 1990, 25:101-107.
79. Meding S.J., et al. Role of γ interferon during infection with Plasmodium chabaudi chabaudi. Infect. Immun. 1990, 58:3671-3678.
80. + T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 2005, 106:1676-1684.
81. Spence P.J., Langhorne J. T cell control of malaria pathogenesis. Curr. Opin. Immunol. 2012, 24:444-448.
82. Hill D.E., et al. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim. Health Res. Rev. 2005, 6:41-61.
83. Bierly A.L., et al. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J. Immunol. 2008, 181:8485-8491.
84. Suzuki Y., et al. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518.
85. + dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011, 35:249-259.
86. Gazzinelli R.T., et al. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994, 153:2533-2543.
87. Hunter C.A., et al. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 1994, 62:2818-2824.
88. Scanga C.A., et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 2002, 168:5997-6001.
89. Koblansky A.A., et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013, 38:119-130.
90. Yarovinsky F., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
91. Baccarella A., et al. Toll-like receptor 7 mediates early innate immune responses to malaria. Infect. Immun. 2013, 10.1128/IAI.00923-13.
92. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005, 201:19-25.
93. + T cells in the Plasmodium yoelii model. J. Immunol. 1999, 163:884-892.
94. Goldszmid R.S., et al. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012, 36:1047-1059.
95. Dzierszinski F., et al. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect. Immun. 2007, 75:5200-5209.
96. + T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
97. Del Rio L., et al. Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors. J. Immunol. 2004, 172:6954-6960.
98. Vossenkamper A., et al. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur. J. Immunol. 2004, 34:3197-3207.
99. Yap G.S., Sher A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 1999, 189:1083-1092.
100. Khan I.A., et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000, 12:483-494.
101. Lamikanra A.A., et al. Malarial anemia: of mice and men. Blood 2007, 110:18-28.
102. Amante F.H., et al. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 2010, 185:3632-3642.
103. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 1996, 184:597-607.
104. Garweg J.G., Candolfi E. Immunopathology in ocular toxoplasmosis: facts and clues. Mem. Inst. Oswaldo Cruz 2009, 104:211-220.
105. Weiss L.M., Dubey J.P. Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 2009, 39:895-901.
106. Wu J.J., et al. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response. Parasitol. Int. 2010, 59:232-241.
107. Wahl S.M. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 1994, 180:1587-1590.
108. Longenecker G., et al. Endocrine expression of the active form of TGF-β1 in the TGF-β1 null mice fails to ameliorate lethal phenotype. Cytokine 2002, 18:43-50.
109. Nagineni C.N., et al. Transforming growth factor-β expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin. Exp. Immunol. 2002, 128:372-378.
110. Pot C., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 2009, 183:797-801.